• Home
  • Contact Us
  • Try it!
  • Blog
  • Vizit Graphs

Follow us

Recent Posts

  • Biovista in World’s Top 20 AI Drug Development Companies March 22, 2019
  • Biovista signs EU-IMI2 research agreement to advance neurotoxicity de-risking in preclinical drug discovery March 15, 2019
  • The increasing importance of predicting AEs & the role of Augmented Intelligence September 10, 2018
  • New Vizit Bibliography pane January 8, 2018
  • Share to Weibo added to Biovista Vizit October 25, 2017

Biovista Vizit

Biovista Vizit

  • Try it!
  • Blog
  • Vizit Graphs

Alzheimer’s and Olfactory impairment

September 3, 2018Alzheimer's, Other, Vizit Graphs
Alzheimer’s and Olfactory impairmentChristos Andronis2018-09-04T12:30:21+00:00
Alzheimer’s and Olfactory impairment

Olfactory impairment: early marker for Alzheimer’s?

Explore the live graph.

Tags: ABETA, ACETYLCHOLINESTERASE, ALZHEIMER'S DISEASE, AMYLOID PRECURSOR PROTEIN, APOLIPOPROTEIN E, BACE1, BDNF, CASP3, CSF2, INSULIN, MAPT, NGF, OLFACTION, PSEN1, TAU, TNF

Post navigation

← Diabetes drugs for Alzheimer’s disease
Circadian rhythm genes →

Vizit Graphs Tag Cloud

CELL PROLIFERATION REMICADE RECEPTOR IMMUNE RESPONSE STREPTOCOCCUS PNEUMONIAE STAPHYLOCOCCUS AUREUS CASP3 RHEUMATOID ARTHRITIS FOXP3 TH17 CELLS HELICOBACTER PYLORI ANGIOGENESIS LISTERIA MONOCYTOGENES METFORMIN DIABETES MELLITUS CANCER IL17A CD4 INFLAMMATION TNF ESCHERICHIA COLI CELL DIVISION BREAST CANCER CTLA4 1-METHYL-4-PHENYL-1-2-3-6-TETRAHYDROPYRIDINE AGING APOPTOTIC PROCESS PARKINSON DISEASE DOXORUBICIN ALZHEIMER'S DISEASE CELL DEATH PSEUDOMONAS AERUGINOSA INSULIN ERBB-2 CANDIDA ALBICANS CELL DIFFERENTIATION IL6 PORPHYROMONAS GINGIVALIS IL23A CLOSTRIDIUM DIFFICILE TP53 IFNG AUTOPHAGY NEURODEGENERATIVE DISORDERS SOD1

© 2019 Biovista Vizit All Rights Reserved.